Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry
Iron overload due to red blood cell (RBC) transfusions is associated with morbidity and mortality in lower-risk myelodysplastic syndrome (MDS) patients.Many studies have suggested improved survival Angled Hood after iron chelation therapy (ICT), but valid data are limited.The aim of this study was to assess the effect of ICT on overall survival and